AI filing briefs · archive

8-K filings in April 2025, explained

811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

7 of 811 briefs match

newest first · times in ET

Victory Capital closes Amundi US deal, issues 17.6 million shares to Amundi

Mixed m&a Written later 1.012.013.025.025.037.01

Victory Capital completed its acquisition of Amundi US on April 1, 2025, issuing Amundi 17.6 million shares, or 21.2% of fully diluted equity, with additional shares expected over six months to bring Amundi's stake to 26.1%. The company raised its net expense synergy target to $110 million from $100 million and expects to achieve it sooner than originally planned. Existing shareholders will own a smaller share of the company, and two Amundi designees joined the board.

  • Closed April 1, 2025; issued 3,293,471 common shares (4.9%) and 14,305,982 non-voting Series A convertible preferred shares, together 21.2% of fully diluted shares
  • Net expense synergy target raised from $100 million to $110 million; about $50 million achieved at closing
  • Pioneer Investments generated 2024 revenue of $544 million and had $119 billion in assets under management as of February 28, 2025
  • Robert Hurst retired from the board effective April 1; Céline Boyer-Chammard and Dominique Carrel-Billiard joined as Amundi designees
Read the filing on SEC.gov ↗
FIVNFive9, Inc. Apr 3, 4:12 PM ET

Five9 cuts about 4% of workforce and expects Q1 results in line with or above guidance

Mixed restructuring Written later 2.022.058.01

Five9 said on April 3, 2025 that its first-quarter 2025 revenue, GAAP net loss per share and non-GAAP net income per share are expected to be in line with or better than its February 20, 2025 guidance. The same day it began a reduction in force of about 4% of global full-time employees, aimed at prioritizing AI and other strategic investments, with estimated charges of $8 million to $10.5 million that will mostly fall in the second and third quarters of 2025.

  • Q1 2025 revenue, GAAP net loss per share and non-GAAP net income per share expected in line with or better than February 20, 2025 guidance; results are preliminary and unaudited.
  • Board approved the reduction in force on March 31, 2025; execution began April 3, 2025, affecting about 4% of global full-time employees.
  • Estimated cash costs of $7 million to $9 million and non-cash costs of $1 million to $1.5 million, mainly in Q2 and Q3 2025; actions expected substantially complete by end of Q2 2025.
  • Five9 will provide Q2 2025 and fiscal 2025 guidance at its earnings call, expected in early May 2025.
Read the filing on SEC.gov ↗

Siddhi Acquisition Corp closes $276 million IPO of 27.6 million units

Neutral financing Written later 1.013.025.038.01

Siddhi Acquisition Corp, a Cayman Islands blank check company, completed its initial public offering on April 2, 2025, selling 27,600,000 units at $10.00 each, including the over-allotment exercised in full. The filing states that $277,380,000 from the IPO and a private placement of units to the sponsor was placed in a U.S.-based trust account, with funds generally not released until a business combination is completed or public shares are redeemed.

  • IPO closed April 2, 2025: 27,600,000 units at $10.00 per unit, gross proceeds of $276,000,000
  • Each unit consists of one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share
  • Private placement of 338,000 units sold to the sponsor at $10.00 per unit, closed alongside the IPO
  • $277,380,000 placed in trust account maintained by Continental Stock Transfer & Trust Company
Read the filing on SEC.gov ↗
TBBKBancorp, Inc. Apr 3, 4:06 PM ET

Bancorp CFO Paul Frenkiel to retire; Martin Egan named interim CFO

Neutral leadership Written later 5.02

The Bancorp, Inc. said its Executive Vice President and Chief Financial Officer, Paul Frenkiel, is retiring, with his retirement agreement signed March 28, 2025. Chief Accounting Officer Martin Egan was appointed interim CFO while the company continues its search for a permanent successor, which it said began last year.

  • Paul Frenkiel, 72, retires as CFO and Secretary; he will consult for the company through December 31, 2025 for a $250,000 fee paid monthly
  • Martin Egan, 57, named Interim CFO on March 28, 2025 and continues as Chief Accounting Officer at a $375,000 annual base salary
  • Frenkiel's 25,561 unvested restricted stock units will vest on the one-year anniversary of his retirement date
  • The company is continuing its formal search for a successor Chief Financial Officer
Read the filing on SEC.gov ↗

Hanover Insurance names Richard Lavey Executive VP and Chief Operating Officer

Neutral leadership Written later 5.02

The Hanover Insurance Group's board appointed Richard W. Lavey, 58, as Executive Vice President and Chief Operating Officer on March 31, 2025, a newly created role. He will lead the development of company strategy and drive closer integration between the business and technology organizations while keeping his current leadership of personal lines and core commercial. For shareholders, the filing signals a senior leadership change, with no financial results or guidance included.

  • Richard W. Lavey, 58, appointed Executive Vice President and Chief Operating Officer effective March 31, 2025
  • Newly created role adds leadership of business strategy and business-technology integration to his existing personal lines and core commercial duties
  • Lavey has been with the company since 2004 and was Executive Vice President and President, Hanover Agency Markets since 2017
Read the filing on SEC.gov ↗
GMEDGLOBUS MEDICAL INC Apr 3, 9:00 AM ET

Globus Medical completes $5.85-per-share cash acquisition of Nevro Corp.

Neutral m&a Written later 2.017.01

Globus Medical completed its previously announced merger with Nevro Corp. on April 3, 2025, making Nevro a wholly owned subsidiary. Nevro shareholders receive $5.85 per share in cash, and Nevro stock stopped trading on the NYSE before the market opened that day.

  • Nevro common stock holders receive $5.85 per share in cash, without interest and subject to withholding taxes.
  • Nevro stock options were cancelled without consideration; RSUs and PSUs convert to cash payments at the Merger Consideration.
  • The Merger Agreement is dated February 6, 2025; Globus says the deal unlocks a $2 billion market opportunity in neuromodulation and beyond.
  • Globus plans to discuss the closing and expected benefits on its first quarter earnings conference call in May.
Read the filing on SEC.gov ↗
VFCV F CORP Apr 3, 6:30 AM ET

VF Corp names Abhishek Dalmia executive VP and chief operating officer

Neutral leadership Written later 5.02

V.F. Corporation appointed Abhishek Dalmia as Executive Vice President and Chief Operating Officer, effective April 3, 2025, overseeing corporate strategy, transformation, digital technology and supply chain operations. He previously served as the company's Executive Vice President and Chief Strategy, Transformation and Digital Officer after joining in March 2024, and his compensation package includes an $800,000 base salary and a fiscal 2026 long-term incentive target of $3,000,000.

  • Abhishek Dalmia, 47, named Executive Vice President and Chief Operating Officer effective April 3, 2025
  • Role covers corporate strategy, transformation, digital technology and supply chain operations
  • Annualized base salary of $800,000 and target annual bonus of 110% of base salary for fiscal 2026
  • Target long-term incentive of $3,000,000 for fiscal 2026, expected to be granted in May 2025
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.